Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page history now shows the latest site revision v3.5.4 being added and the previous revision v3.5.3 removed. This indicates a backend/maintenance update to the ClinicalTrials.gov page rendering rather than changes to the study record data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated the displayed ClinicalTrials.gov interface/app revision label from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.5.0 added to the history; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check110 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1. A funding/operating-status notice was removed; these updates pertain to site-wide notices rather than the study record content.SummaryDifference0.5%

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.